Medtronic plc (LON:0Y6X)
London · Delayed Price · Currency is GBP · Price in USD 96.98
-0.86 (-0.88%)
At close: Feb 20, 2026
Revenue
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 23, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 26, 2013 |
Cardiac Rhythm & Heart Failure Revenue | 7.13B | 6.39B | 6.00B | |||||||||||
Cardiac Rhythm & Heart Failure Revenue Growth | 11.48% | 6.62% | 3.67% | |||||||||||
Structural Heart & Aortic Revenue | 3.76B | 3.55B | 3.36B | |||||||||||
Structural Heart & Aortic Revenue Growth | 5.77% | 5.84% | -0.15% | |||||||||||
Coronary & Peripheral Vascular Revenue | 2.63B | 2.54B | 2.48B | |||||||||||
Coronary & Peripheral Vascular Revenue Growth | 3.71% | 2.30% | 4.34% | |||||||||||
Cardiovascular Revenue | 13.51B | 12.48B | 11.83B | |||||||||||
Cardiovascular Revenue Growth | 8.28% | 5.49% | 2.68% | |||||||||||
Cranial & Spinal Technologies Revenue | 5.16B | 4.97B | 4.76B | |||||||||||
Cranial & Spinal Technologies Revenue Growth | 3.80% | 4.56% | 6.85% | |||||||||||
Specialty Therapies Revenue | 2.95B | 2.94B | 2.91B | |||||||||||
Specialty Therapies Revenue Growth | 0.37% | 1.21% | 3.20% | |||||||||||
Neuromodulation Revenue | 2.05B | 1.93B | 1.75B | |||||||||||
Neuromodulation Revenue Growth | 5.95% | 10.65% | 3.13% | |||||||||||
Neuroscience Revenue | 10.16B | 9.85B | 9.41B | |||||||||||
Neuroscience Revenue Growth | 3.15% | 4.68% | 4.99% | |||||||||||
Surgical & Endoscopy Revenue | 6.65B | 6.50B | 6.51B | |||||||||||
Surgical & Endoscopy Revenue Growth | 2.40% | -0.15% | 5.79% | |||||||||||
Acute Care & Monitoring Revenue | 1.99B | 1.91B | 1.91B | |||||||||||
Acute Care & Monitoring Revenue Growth | 4.03% | 0.05% | 3.86% | |||||||||||
Medical Surgical Revenue | 8.64B | 8.41B | 8.42B | |||||||||||
Medical Surgical Revenue Growth | 2.76% | -0.12% | 5.36% | |||||||||||
Diabetes Revenue | 3.00B | 2.76B | 2.49B | |||||||||||
Diabetes Revenue Growth | 8.97% | 10.73% | 9.99% | |||||||||||
Other Segment Revenue | 170.00M | 137.00M | 221.00M | |||||||||||
Other Segment Revenue Growth | 24.09% | -38.01% | -55.35% | |||||||||||
Revenue (Other) | 2.00M | -89.00M | 1.00M | |||||||||||
Revenue (Total) | 35.48B | 33.54B | 32.36B | |||||||||||
Revenue (Total) Growth | 5.80% | 3.62% | 3.64% |
Revenue by Geography
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 23, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 26, 2013 |
U.S. Revenue | 17.78B | 17.17B | 16.56B | |||||||||||
U.S. Revenue Growth | 3.55% | 3.68% | 1.15% | |||||||||||
Non-U.S. Developed Markets Revenue | - | 10.20B | 9.98B | |||||||||||
Non-U.S. Developed Markets Revenue Growth | - | 2.21% | 6.07% | |||||||||||
Emerging Markets Revenue | - | 6.20B | 5.82B | |||||||||||
Emerging Markets Revenue Growth | - | 6.47% | 6.92% | |||||||||||
Total International Revenue | 17.70B | 16.37B | 15.80B | |||||||||||
Total International Revenue Growth | 8.18% | 3.56% | 6.38% | |||||||||||
Revenue (Other) | - | 1.00M | - | |||||||||||
Revenue (Total) | 35.48B | 33.54B | 32.36B | |||||||||||
Revenue (Total) Growth | 5.80% | 3.62% | 3.64% |
EBIT
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 23, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 26, 2013 |
Cardiovascular Operating Profit | - | 4.80B | 4.47B | |||||||||||
Cardiovascular Operating Profit Growth | - | 7.31% | 0.49% | |||||||||||
Neuroscience Operating Profit | - | 4.18B | 3.94B | |||||||||||
Neuroscience Operating Profit Growth | - | 6.17% | 6.14% | |||||||||||
Medical Surgical Operating Profit | - | 3.04B | 3.17B | |||||||||||
Medical Surgical Operating Profit Growth | - | -4.04% | 4.00% | |||||||||||
Diabetes Operating Profit | - | 491.00M | 394.00M | |||||||||||
Diabetes Operating Profit Growth | - | 24.62% | 2.87% | |||||||||||
Operating Income (Total) | 6.03B | 5.96B | 5.14B | |||||||||||
Operating Income (Total) Growth | 1.28% | 15.77% | -6.22% |
Key Performance Indicators
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 26, 2013 |
Cardiovascular Organic Revenue Growth | 6.30% | 5.00% | |||||||||||
Neuroscience Organic Revenue Growth | 5.20% | 5.20% | |||||||||||
Medical Surgical Organic Revenue Growth | 0.80% | 4.70% | |||||||||||
Diabetes Organic Revenue Growth | 11.50% | 8.60% | |||||||||||
Total Organic Revenue Growth | 4.90% | 5.20% |
Updated Jan 23, 2026. Data Source: Fiscal.ai.